{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:36:49Z","timestamp":1789137409702,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T00:00:00Z","timestamp":1518393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Uniwersytet Gdanski","award":["538-L140-B258-16"],"award-info":[{"award-number":["538-L140-B258-16"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuromol Med"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s12017-018-8482-1","type":"journal-article","created":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T09:52:50Z","timestamp":1518429170000},"page":"112-123","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Correction of Huntington\u2019s Disease Phenotype by Genistein-Induced Autophagy in the Cellular Model"],"prefix":"10.1007","volume":"20","author":[{"given":"Karolina","family":"Pierzynowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Gaffke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Ha\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagoda","family":"Mantej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Niedzia\u0142ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Brokowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4042-7466","authenticated-orcid":false,"given":"Grzegorz","family":"W\u0119grzyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,12]]},"reference":[{"key":"8482_CR1","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/mds.26020","volume":"29","author":"N Aronin","year":"2014","unstructured":"Aronin, N., & DiFiglia, M. (2014). Huntingtin-lowering strategies in Huntington\u2019s disease: Antisense oligonucleotides, small RNAs, and gene editing. Movement Disorders, 29, 1455\u20131461.","journal-title":"Movement Disorders"},{"key":"8482_CR2","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.neuron.2015.10.038","volume":"88","author":"M Ba\u00f1ez-Coronel","year":"2015","unstructured":"Ba\u00f1ez-Coronel, M., Ayhan, F., Tarabochia, A. D., Zu, T., Perez, B. A., Tusi, S. K., et al. (2015). RAN translation in Huntington disease. Neuron, 88, 667\u2013677.","journal-title":"Neuron"},{"key":"8482_CR3","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/nature06022","volume":"448","author":"EJ Bennett","year":"2007","unstructured":"Bennett, E. J., Shaler, T. A., Woodman, B., Ryu, K. Y., Zaitseva, T. S., Becker, C. H., et al. (2007). Global changes to the ubiquitin system in Huntington\u2019s disease. Nature, 448, 704\u2013708.","journal-title":"Nature"},{"key":"8482_CR4","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1038\/sj.emboj.7601592","volume":"26","author":"N Bhutani","year":"2007","unstructured":"Bhutani, N., Venkatraman, P., & Goldberg, A. L. (2007). Puromycin-sensitive aminopeptidase is the major peptidase responsible for digesting polyglutamine sequences released by proteasomes during protein degradation. EMBO Journal, 26, 1385\u20131396.","journal-title":"EMBO Journal"},{"key":"8482_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ana.22643","volume":"71","author":"J Ruijter de","year":"2012","unstructured":"de Ruijter, J., Valstar, M. J., Narajczyk, M., Wegrzyn, G., Kulik, W., Ijlst, L., et al. (2012). Genistein in Sanfilippo disease: A randomized controlled crossover trial. Annals of Neurology, 71, 110\u2013120.","journal-title":"Annals of Neurology"},{"key":"8482_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1100\/tsw.2008.60","volume":"8","author":"S Finkbeiner","year":"2008","unstructured":"Finkbeiner, S., & Mitra, S. (2008). The ubiquitin-proteasome pathway in Huntington\u2019s disease. Scientific World Journal, 8, 421\u2013433.","journal-title":"Scientific World Journal"},{"key":"8482_CR7","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1515\/hsz-2012-0218","volume":"393","author":"P Galka-Marciniak","year":"2012","unstructured":"Galka-Marciniak, P., Urbanek, M. O., & Krzyzosiak, W. J. (2012). Triplet repeats in transcripts: Structural insights into RNA toxicity. Biological Chemistry, 393, 1299\u20131315.","journal-title":"Biological Chemistry"},{"key":"8482_CR8","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","volume":"27","author":"JM Gil","year":"2008","unstructured":"Gil, J. M., & Rego, A. C. (2008). Mechanisms of neurodegeneration on Huntington\u2019s disease. European Journal of Neuroscience, 27, 2803\u20132820.","journal-title":"European Journal of Neuroscience"},{"key":"8482_CR9","first-page":"w14306","volume":"146","author":"P Goloubinoff","year":"2016","unstructured":"Goloubinoff, P. (2016). Mechanisms of protein homeostasis in health, aging and disease. Swiss Medical Weekly, 146, w14306.","journal-title":"Swiss Medical Weekly"},{"key":"8482_CR10","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1111\/bph.12792","volume":"171","author":"F Gros","year":"2014","unstructured":"Gros, F., & Muller, S. (2014). Pharmacological regulators of autophagy and their link with modulators of lupus disease. British Journal of Pharmacology, 171, 4337\u20134359.","journal-title":"British Journal of Pharmacology"},{"key":"8482_CR11","doi-asserted-by":"publisher","first-page":"22477","DOI":"10.1074\/jbc.M114.584342","volume":"289","author":"LT Haas","year":"2014","unstructured":"Haas, L. T., Kostylev, M. A., & Strittmatter, S. M. (2014). Therapeutic molecules and endogenous ligands regulate the interaction between brain cellular prion protein (PrPC) and metabotropic glutamate receptor 5 (mGluR5). Journal of Biological Chemistry, 289, 22477\u201328460.","journal-title":"Journal of Biological Chemistry"},{"key":"8482_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1423-0127-16-26","volume":"16","author":"J Jak\u00f3bkiewicz-Banecka","year":"2009","unstructured":"Jak\u00f3bkiewicz-Banecka, J., Piotrowska, E., Narajczyk, M., Bara\u0144ska, S., & Wegrzyn, G. (2009). Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway. Journal of Biomedical Science, 16, 26.","journal-title":"Journal of Biomedical Science"},{"key":"8482_CR13","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/hmg\/10.10.1049","volume":"10","author":"NR Jana","year":"2001","unstructured":"Jana, N. R., Zemskov, E. A., Wang, G., & Nukina, N. (2001). Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release. Human Molecular Genetics, 10, 1049\u20131059.","journal-title":"Human Molecular Genetics"},{"key":"8482_CR14","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ymgme.2013.06.012","volume":"109","author":"KH Kim","year":"2013","unstructured":"Kim, K. H., Dodsworth, C., Paras, A., & Burton, B. K. (2013). High dose genistein aglycone therapy is safe in patients with mucopolysaccharidoses involving the central nervous system. Molecular Genetics and Metabolism, 109, 382\u2013385.","journal-title":"Molecular Genetics and Metabolism"},{"key":"8482_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neuroscience.2015.04.026","volume":"302","author":"D Lecca","year":"2015","unstructured":"Lecca, D., Nevin, D. K., Mulas, G., Casu, M. A., Diana, A., Rossi, D., et al. (2015). Neuroprotective and anti-inflammatory properties of a novel non-thiazolidinedione PPAR\u03b3 agonist in vitro and in MPTP-treated mice. Neuroscience, 302, 23\u201335.","journal-title":"Neuroscience"},{"key":"8482_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ymgme.2009.06.013","volume":"98","author":"M Malinowska","year":"2009","unstructured":"Malinowska, M., Wilkinson, F. L., Bennett, W., Langford-Smith, K. J., O\u2019Leary, H. A., Jakobkiewicz-Banecka, J., et al. (2009). Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB mice. Molecular Genetics and Metabolism, 98, 235\u2013242.","journal-title":"Molecular Genetics and Metabolism"},{"key":"8482_CR17","doi-asserted-by":"publisher","first-page":"e14192","DOI":"10.1371\/journal.pone.0014192","volume":"5","author":"M Malinowska","year":"2010","unstructured":"Malinowska, M., Wilkinson, F. L., Langford-Smith, K. J., Langford-Smith, A., Brown, J. R., Crawford, B. E., et al. (2010). Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic disease. PLoS ONE, 5, e14192.","journal-title":"PLoS ONE"},{"key":"8482_CR18","doi-asserted-by":"publisher","first-page":"e0117223","DOI":"10.1371\/journal.pone.0117223","volume":"10","author":"ET Menze","year":"2015","unstructured":"Menze, E. T., Esmat, A., Tadros, M. G., Abdel-Naim, A. B., & Khalifa, A. E. (2015). Genistein improves 3-NPA-induced memory impairment in ovariectomized rats: Impact of its antioxidant, anti-inflammatory and acetylcholinesterase modulatory properties. PLoS ONE, 10, e0117223.","journal-title":"PLoS ONE"},{"key":"8482_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neuropharm.2016.01.007","volume":"105","author":"ET Menze","year":"2016","unstructured":"Menze, E. T., Esmat, A., Tadros, M. G., Khalifa, A. E., & Abdel-Naim, A. B. (2016). Genistein improves sensorimotor gating: Mechanisms related to its neuroprotective effects on the striatum. Neuropharmacology, 105, 35\u201346.","journal-title":"Neuropharmacology"},{"key":"8482_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","volume":"140","author":"N Mizushima","year":"2010","unstructured":"Mizushima, N., Yoshimori, T., & Levine, B. (2010). Methods in mammalian autophagy research. Cell, 140, 313\u2013326.","journal-title":"Cell"},{"key":"8482_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000369111","volume":"34","author":"MK Morreale","year":"2015","unstructured":"Morreale, M. K. (2015). Huntington\u2019s disease: Looking beyond the movement disorder. Advances in Psychosomatic Medicine, 34, 135\u2013142.","journal-title":"Advances in Psychosomatic Medicine"},{"key":"8482_CR22","doi-asserted-by":"publisher","first-page":"9378","DOI":"10.1038\/srep09378","volume":"5","author":"M Moskot","year":"2015","unstructured":"Moskot, M., Jak\u00f3bkiewicz-Banecka, J., Kloska, A., Smoli\u0144ska, E., Mozolewski, P., Malinowska, M., et al. (2015a). Modulation of expression of genes involved in glycosaminoglycan metabolism and lysosome biogenesis by flavonoids. Sci Rep, 5, 9378.","journal-title":"Sci Rep"},{"key":"8482_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11010-015-2458-3","volume":"407","author":"M Moskot","year":"2015","unstructured":"Moskot, M., Jak\u00f3bkiewicz-Banecka, J., Smoli\u0144ska, E., Piotrowska, E., W\u0119grzyn, G., & Gabig-Cimi\u0144ska, M. (2015b). Effects of flavonoids on expression of genes involved in cell cycle regulation and DNA replication in human fibroblasts. Molecular and Cellular Biochemistry, 407, 97\u2013109.","journal-title":"Molecular and Cellular Biochemistry"},{"key":"8482_CR24","doi-asserted-by":"publisher","first-page":"17054","DOI":"10.1074\/jbc.M114.555300","volume":"289","author":"M Moskot","year":"2014","unstructured":"Moskot, M., Montefusco, S., Jak\u00f3bkiewicz-Banecka, J., Mozolewski, P., W\u0119grzyn, A., Di Bernardo, D., et al. (2014). The phytoestrogen genistein modulates lysosomal metabolism and transcription factor EB (TFEB) activation. Journal of Biological Chemistry, 289, 17054\u201317069.","journal-title":"Journal of Biological Chemistry"},{"key":"8482_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.phrs.2014.10.008","volume":"91","author":"S Petrosino","year":"2015","unstructured":"Petrosino, S., Ahmad, A., Marcolongo, G., Esposito, E., Allar\u00e0, M., Verde, R., et al. (2015). Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain. Pharmacological Research, 91, 9\u201314.","journal-title":"Pharmacological Research"},{"key":"8482_CR26","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/sj.ejhg.5201623","volume":"14","author":"E Piotrowska","year":"2006","unstructured":"Piotrowska, E., Jak\u00f3bkiewicz-Banecka, J., Bara\u0144ska, S., Tylki-Szyma\u0144ska, A., Czartoryska, B., Wegrzyn, A., et al. (2006). Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses. European Journal of Human Genetics, 14, 846\u2013852.","journal-title":"European Journal of Human Genetics"},{"issue":"127","key":"8482_CR27","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.puhe.2012.12.018","volume":"2013","author":"C Pritchard","year":"2013","unstructured":"Pritchard, C., Mayers, A., & Baldwin, D. (2013). Changing patterns of neurological mortality in the 10 major developed countries\u20141979\u20132010. Public Health, 2013(127), 357\u2013368.","journal-title":"Public Health"},{"key":"8482_CR28","doi-asserted-by":"publisher","first-page":"ra103","DOI":"10.1126\/scisignal.2005633","volume":"7","author":"WM Pryor","year":"2014","unstructured":"Pryor, W. M., Biagioli, M., Shahani, N., Swarnkar, S., Huang, W. C., Page, D. T., et al. (2014). Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington\u2019s disease. Science Signal, 7, ra103.","journal-title":"Science Signal"},{"key":"8482_CR29","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1080\/15384101.2015.1033595","volume":"14","author":"T Ratovitski","year":"2015","unstructured":"Ratovitski, T., Arbez, N., Stewart, J. C., Chighladze, E., & Ross, C. A. (2015). PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant Huntingtin and is impaired in Huntington\u2019s disease (HD). Cell Cycle, 14, 1716\u20131729.","journal-title":"Cell Cycle"},{"key":"8482_CR30","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/hmg\/11.9.1107","volume":"11","author":"B Ravikumar","year":"2002","unstructured":"Ravikumar, B., Duden, R., & Rubinsztein, D. C. (2002). Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Human Molecular Genetics, 11, 1107\u20131117.","journal-title":"Human Molecular Genetics"},{"key":"8482_CR31","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/ng1362","volume":"36","author":"B Ravikumar","year":"2004","unstructured":"Ravikumar, B., Vacher, C., Berger, Z., Davies, J. E., Luo, S., Oroz, L. G., et al. (2004). Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nature Genetics, 36, 585\u2013595.","journal-title":"Nature Genetics"},{"key":"8482_CR32","doi-asserted-by":"publisher","first-page":"34755","DOI":"10.1038\/srep34755","volume":"6","author":"S Sameni","year":"2016","unstructured":"Sameni, S., Syed, A., Marsh, J. L., & Digman, M. A. (2016). The phasor-FLIM fingerprints reveal shifts from OXPHOS to enhanced glycolysis in Huntington disease. Scientific Reports, 6, 34755.","journal-title":"Scientific Reports"},{"key":"8482_CR33","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/mds.26331","volume":"30","author":"KM Shannon","year":"2015","unstructured":"Shannon, K. M., & Fraint, A. (2015). Therapeutic advances in Huntington\u2019s disease. Movement Disorders, 30, 1539\u20131546.","journal-title":"Movement Disorders"},{"key":"8482_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-1-59745-157-4_3","volume":"445","author":"E Tasdemir","year":"2008","unstructured":"Tasdemir, E., Galluzzi, L., Maiuri, M. C., Criollo, A., Vitale, I., Hangen, E., et al. (2008). Methods for assessing autophagy and autophagic cell death. Methods in Molecular Biology, 445, 29\u201376.","journal-title":"Methods in Molecular Biology"},{"key":"8482_CR35","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.chroma.2004.10.048","volume":"1073","author":"TH Tsai","year":"2005","unstructured":"Tsai, T. H. (2005). Concurrent measurement of unbound genistein in the blood, brain and bile of anesthetized rats using microdialysis and its pharmacokinetic application. Journal of Chromatography A, 1073, 317\u2013322.","journal-title":"Journal of Chromatography A"},{"key":"8482_CR36","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1042\/BST0380695","volume":"38","author":"G Wegrzyn","year":"2010","unstructured":"Wegrzyn, G., Jak\u00f3bkiewicz-Banecka, J., Gabig-Cimi\u0144ska, M., Piotrowska, E., Narajczyk, M., Kloska, A., et al. (2010). Genistein: A natural isoflavone with a potential for treatment of genetic diseases. Biochemical Society Transactions, 38, 695\u2013701.","journal-title":"Biochemical Society Transactions"},{"key":"8482_CR37","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/aps.2013.5","volume":"34","author":"YP Yang","year":"2013","unstructured":"Yang, Y. P., Hu, L. F., Zheng, H. F., Mao, C. J., Hu, W. D., Xiong, K. P., et al. (2013). Application and interpretation of current autophagy inhibitors and activators. Acta Pharmacologica Sinica, 34, 625\u2013635.","journal-title":"Acta Pharmacologica Sinica"},{"key":"8482_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fnmol.2016.00027","volume":"9","author":"T Zhao","year":"2016","unstructured":"Zhao, T., Hong, Y., Li, X. J., & Li, S. H. (2016). Subcellular clearance and accumulation of Huntington disease protein: A mini-review. Frontiers in Molecular Neuroscience, 9, 27.","journal-title":"Frontiers in Molecular Neuroscience"}],"container-title":["NeuroMolecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12017-018-8482-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-018-8482-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-018-8482-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T19:15:49Z","timestamp":1549912549000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12017-018-8482-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,12]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["8482"],"URL":"https:\/\/doi.org\/10.1007\/s12017-018-8482-1","relation":{},"ISSN":["1535-1084","1559-1174"],"issn-type":[{"value":"1535-1084","type":"print"},{"value":"1559-1174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,12]]},"assertion":[{"value":"4 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The use of genistein in treatment of Huntington\u2019s disease is a subject of patent application (No. P.417983, submitted to Polish Patent Office). No other conflicts of interest are declared by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}